UCB1%1OCT2027UCB1%1OCT2027UCB1%1OCT2027

UCB1%1OCT2027

No trades
See on Supercharts

Key terms


Outstanding amount
‪150.00 M‬EUR
Face value
100,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.00% (Fixed)
Coupon frequency
Annual
Yield to maturity
1.00%
Maturity date
Oct 1, 2027
Term to maturity
2 years

About UCB1%1OCT2027


Issuer
Sector
Health Technology
Home page
Issue date
Oct 1, 2020
ISIN
BE0002730118
FIGI
BBG00XKLH6C3
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.